A Meta-Analysis of the Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Heart Failure and Preserved Ejection Fraction

Am J Cardiol. 2022 Feb 1:164:138-141. doi: 10.1016/j.amjcard.2021.10.017. Epub 2021 Nov 17.

Authors

Ahmad Al-Abdouh¹, Mohammed Mhanna², Mahmoud Barbarawi³, Waiel Abusnina⁴, Vedant A Gupta⁵

Affiliations

¹ Division of Hospital Medicine, University of Kentucky, Lexington, Kentucky.
² Department of Internal Medicine, University of Toledo, Toledo, Ohio.
³ Department of Cardiology, University of Connecticut, Framingham, Connecticut.
⁴ Department of Cardiology, Creighton University, Omaha, Nebraska.
⁵ Division of Cardiovascular Medicine, University of Kentucky, Lexington, Kentucky.

PMID: 34799085
DOI: 10.1016/j.amjcard.2021.10.017

No abstract available

Publication types

Letter
Meta-Analysis

MeSH terms

Cardiovascular Diseases* / mortality
Heart Failure* / complications
Heart Failure* / drug therapy
Heart Failure* / physiopathology
Hospitalization* / statistics & numerical data
Humans
Mortality
Proportional Hazards Models
Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use
Stroke Volume / physiology

Substances

Sodium-Glucose Transporter 2 Inhibitors